Abstract
Anti-M antibodies are usually of IgM, appear as cold agglutinins and are clinically insignificant. We are reporting two cases of anti-M in cases of solid tumors where the anti-M caused discrepancy in blood grouping, reacted in coombs phase of crossmatching. Anti-M in first case showed dosage effect. These antibodies can be clinical significant when detected in coombs phase, making M antigen negative coombs compatible unit transfusion imperative.
References
Brecher ME (ed) (2005) AABB Technical Manual. 15th ed. American association of blood banks, Bethesda p. 340
Duguid J, Bromilow I, Entwistle G, Wilkinson R (1995) Haemolytic disease of the newborn due to anti-M. Vox Sang 68:195–196
Thompson DJ, Stults DZ, Daniel SJ (1989) Anti-M antibody in pregnancy. Obstet Gynecol Surv 44(9):637–641
Sancho JM, Pujol M, Fernandez F, Soler FM, Manzano P, Felio E (1998) Delayed hemolytic transfusion reaction due to anti M antibody. Br J Haematol 103:268–269
Tondon R, Kataria R, Chaudhry R (2008) Anti-M: report of two cases and review of literature. Asian J Transfus Sci. 2:81–83
Harmening D (2005) Modern blood banking and transfusion practices, 5th edn. F.A. Davis company, Philadelphia, p 166
Rangarajan K, Subramanian A, Agrawal D, Chatterjee K (2010) Trauma patient with M-antibody. Indian J Pathol Microbiol 53:574–575
Khalid S, Dantes R, Varghese S, Al Hakawati I (2011) Naturally occurring anti M complicating ABO grouping. Indian J Pathol Microbiol 54:170–172
Klein HG, Anstee DJ (2005) Other red cell antigens. In: Klein HG, Anstee DJ (eds) Mollison’s blood transfusion in clinical medicine, 11th edn. Blackwell, London, pp 220–221
Klein SidneyJ, Reilly EmmettB, James J (1963) Matsushima an uncommon blood group isoantibody (anti-M) in neoplastic disease. Nature 197:393–394
Selseleh M (MS), Esmaili J (BS) (2006) A case study of anti-M with IgG type and clinical significance. SJIBTO 3(1): 73–78 (Abstract)
Parry-Jones N, Gore ME, Taylor J, Treleaven JG (1999) Delayed hemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer. Clin Lab Haematol 21(6):407–408 1999 Dec
Acknowledgments
We would like to thank Mr. Sumit Gupta (Bio-Rad) for his contribution and support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Soni, S.K., Goyal, H., Sood, S.K. et al. Anti-M Antibody in Solid Tumors-Two Case Reports. Indian J Hematol Blood Transfus 30 (Suppl 1), 49–53 (2014). https://doi.org/10.1007/s12288-013-0243-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-013-0243-6